====== Paul Hendry ====== {{ :screen_shot_2022-03-16_at_7.06.22_pm.png?150|}} Dr. **Paul Hendry** is a Canadian cardiac surgeon based in Ottawa, Ontario. He is notable in the [[COVID-19 pandemic]] due to his position with the [[College of Physicians and Surgeons of Ontario]]. ===== Education ===== Dr. Hendry earned his MD from the [[University of Ottawa]] in 1981, where he completed his Residency Training in Cardiovascular and Thoracic Surgery. During that time, he earned an MSc in Physiology. ==== Certifications ==== He is certified as a Fellow of the [[Royal College of Physicians and Surgeons of Canada]] (FRCPC) in General Surgery. In 1989, he received further certification in Cardiovascular and Thoracic Surgery, and is a Diplomat of the [[American Board of Surgery]]. ===== Affiliations ===== ==== Duke University ==== Following his residency, he undertook a research fellowship at [[Duke University]] in Durham, North Carolina, for two years. ==== University of Ottawa (1990-present) ==== Dr. Hendry is a Professor of Cardiac Surgery at the [[University of Ottawa]].((//Hendry, Paul.// University of Ottawa Heart Institute. Retrieved March 16, 2022, from https://archive.ph/I9a0Q)) He is also a Cardiac Surgeon and Director of the Mechanical Circulatory Devices Program at the [[university_of_ottawa:University of Ottawa Heart Institute]], where he began as a staff surgeon in 1990. ===== Research ===== Dr. Hendry’s research interests and publications are in the areas of myocardial preservation, electrophysiology and surgery for heart failure, including the use of ventricular assist devices, left ventricular remodelling and transplantation. ==== Funding ==== Dr. Hendry has received research funding from the [[Canadian Institutes of Health Research]] (CIHR) and the [[Heart and Stroke Foundation of Ontario]].((Meirovich, Y. F., Veinot, J. P., Kuroski de Bold, M. L., Haddad, H., Davies, R. A., Masters, R. G., Hendry, P. J., & de Bold, A. J. (2008). //Relationship Between Natriuretic Peptides and Inflammation: Proteomic Evidence Obtained During Acute Cellular Cardiac Allograft Rejection in Humans.// The Journal of Heart and Lung Transplantation, 27(1), 31–37. https://doi.org/10.1016/j.healun.2007.09.025))